Close

Monthly Archives: June 2008

More reasons not to take psychiatric drugs

It’s now well known that the newer antidepressants like Prozac, Paxil, Zoloft and Celexa cause suicidal thoughts and behavior, and can worsen depression. Psychiatric drugs sustained another blow when the FDA recently declared that yet another group of these chemical agents causes the very problems that the drugs are supposed to treat. This time the […]

Read More

Antidepressant-induced suicidality and violence: more about deception than science

Report Presented at the September 14, 2004 Press Conference Sponsored by the Alliance for Human Research Protection (AHRP) at the FDA Public Hearing on Antidepressants and Suicide. Antidepressant-Induced Suicidality and Violence: More About Deception than Science Observations Made at the FDA Hearings Press Conference, September 14, 2004 By Peter R. Breggin, M.D. The FDA is […]

Read More

The Proven Dangers of Antidepressants

by Peter R. Breggin, M.D. On March 22 the FDA issued an extraordinary “Public Health Advisory” that cautioned about the risks associated with the whole new generation of antidepressants including Prozac and its knock offs, Zoloft, Paxil, Luvox, Celexa, and Lexapro, as well as Wellbutrin, Effexor, Serzone, and Remeron. The warning followed a public hearing […]

Read More

FDA Issues Public Health Advisory on Cautions for Use of Antidepressants in Adults and Children

The Food and Drug Administration today issued a Public Health Advisory that provides further cautions to physicians, their patients, and families and caregivers of patients about the need to closely monitor both adults and children with depression, especially at the beginning of treatment, or when the doses are changed with either an increase or decrease […]

Read More

The FDA Continues to Affirm Antidepressant Risks First Identified in my 1991 Book Toxic Psychiatry By Peter R. Breggin, M.D. Ithaca, New York www.breggin.com   In 2004 the FDA issued a black box warning about the increased risk of suicidality in children taking the newer antidepressants, including the SSRIs (Prozac, Zoloft, Paxil, Luvox, Celexa, and […]

Read More

Psychiatric Reform Accomplishments

of Peter Breggin, M.D., 1954 to the Present   Many of Dr. Breggin’s accomplishments as a reformer are documented in detail in The Conscience of Psychiatry: The Reform Work of Peter R. Breggin, M.D. (2009). This biographical tribute to Dr. Breggin’s work draws on more than half-a-century of media and more than 70 special contributions from […]

Read More

FDA actions and shortcomings

Dr. Breggin’s educational campaigns and his scientific research contributed have put pressure on the FDA to change the contents of numerous FDA-approved labels for psychiatric drugs, including the neuroleptic (antipsychotic) drugs and the newer antidepressants. Dr. Breggin’s articles about the FDA, especially the implications of recent label changes, can be found on this website in […]

Read More

Psychiatric Drug Adverse Reactions (Side Effects) and Medication Spellbinding

  Dr. Peter Breggin’s new concept of medication spellbinding provides insights into why so many people take psychiatric drugs when the drugs are doing more harm than good. Psychiatric drugs, and all other drugs that affect the mind, spellbind the individual by masking their adverse mental effects from the individual taking the drugs. If the […]

Read More